Posted on 5/25/17
Peak Physical Therapy & Sports Performance Named by Norwell Chamber as Business of the Year
Peak Physical Therapy & Sports Performance, a South Shore practice specializing in unique programs that provides comprehensive treatment in orthopedic, spine and sports medicine specialties, has . . .
Posted on 5/25/17
ImmunoGen (IMGN) Investor Presentation - Slideshow
The following slide deck was published by ImmunoGen, Inc. in conjunction with this event. 116READ FULL ARTICLE HERE
Posted on 5/25/17
Syndax Prices Public Offering of Common Stock
WALTHAM, Mass., May 24, 2017 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals, Inc. (Nasdaq:SNDX) announced today the pricing of an underwritten public offering of 3,750,000 shares of its . . .
Posted on 5/25/17
CCRM Network to Open Innovative Fertility Treatment Center in Boston
CCRM, a leading infertility treatment network, is opening its newest location in Boston on June 7, 2017. CCRM Boston is co-founded by board certified reproductive endocrinologists, . . .
Posted on 5/25/17
Alnylam Pharmaceuticals Prices Public Offering of Common Stock
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced the pricing of an underwritten public offering of 5,000,000 shares of its . . .
Posted on 5/25/17
Concert Pharmaceuticals Announces Shareholder Approval of CTP-656 Asset Purchase Agreement with Vertex Pharmaceuticals
LEXINGTON, Mass.--(BUSINESS WIRE)--Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that in connection with its annual shareholder meeting, Concert shareholders voted to approve the asset purchase agreement . . .
Posted on 5/25/17
Cerveau Technologies Collaborates With Singapore’s Clinical Imaging Research Centre
BOSTON--(BUSINESS WIRE)--Cerveau Technologies, Inc. today announced a research collaboration with the Clinical Imaging Research Centre (CIRC), a joint venture by the Agency for Science, Technology and . . .
Posted on 5/24/17
New Data from Emulate's Asthma-on-Chip Presented at American Thoracic Society Annual Meeting
Emulate Inc. presented data today that shows expanded functionality in modeling viral infection on the Small Airway Lung-Chip. This advancement opens new opportunities for studying viral-induced . . .
Posted on 5/24/17
Albireo Prices $45.1 Million Public Offering of Common Stock
BOSTON, May 24, 2017 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (NASDAQ:ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, announced today the . . .
Posted on 5/24/17
Berkshire Hathaway And Sequoia Fund: As Seen Through Alphabet, Amazon, And Apple
IntroductionFor the week that ended Friday, one could focus on short-term price movements or long-term investment thinking. As my week evolved I did both, which produced . . .
Posted on 5/24/17
Albireo Announces Proposed Public Offering of Common Stock
BOSTON, May 23, 2017 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (NASDAQ:ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, announced today that . . .
Posted on 5/24/17
MetaStat Expands Therapeutic and Companion Diagnostic Intellectual Property Portfolio
BOSTON--(BUSINESS WIRE)--MetaStat, Inc. (OTCQB: MTST), a personalized medicine company developing therapeutic and diagnostic treatment solutions for cancer patients, announced today it received from the United States . . .
Posted on 5/24/17
Alnylam Pharmaceuticals Proposes Public Offering of Common Stock
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced the commencement of an underwritten public offering of 5,000,000 shares of its . . .
Posted on 5/23/17
Thermo Fisher Scientific (TMO) Investor Presentation - Slideshow
The following slide deck was published by Thermo Fisher Scientific Inc. in conjunction with this event. 1103READ FULL ARTICLE HERE
Posted on 5/23/17
Acceleron Pharma: On Sale After 25% Drop?
"There are three things all wise men fear: the sea in storm, a night with no moon, and the anger of a gentle man." ? Patrick . . .
Posted on 5/23/17
Paratek Pharmaceuticals: The 1 Antibiotic Stock To Buy Now
Paratek Pharmaceuticals Inc. (NASDAQ:PRTK) is a clinical stage biopharmaceutical company which is engaged in the development and commercialization of tetracycline based therapeutics. The company recently reported . . .
Posted on 5/22/17
PCI Biotech and RXi Pharmaceuticals Extend Research Collaboration to the Field of Immuno-oncology
PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company, and RXi Pharmaceuticals (NASDAQ: RXII) a biotechnology company focused on developing novel RNAi therapeutics for significant un-met . . .
Posted on 5/22/17
IDC Health Insights Reveals Winners of 2017 HealthTech Rankings Top 50 and Enterprise Top 25
FRAMINGHAM, Mass.--(BUSINESS WIRE)--IDC Health Insights today revealed the winners of the 2017 HealthTech Rankings. These rankings feature the leading global information technology (IT) suppliers to healthcare . . .
Posted on 5/22/17
Biostage Announces Receipt of Nasdaq Listing Determination
Biostage Inc., (Nasdaq: BSTG), a biotechnology company developing bioengineered organ implants to treat cancers and other life-threatening conditions of the esophagus, bronchus and trachea, announced today . . .
Posted on 5/22/17
Why Long-Term Investors Should Prefer Celgene Over Biogen
Biogen (NASDAQ:BIIB) has enjoyed some good news lately. The spinal muscular atrophy drug that it licensed from Ionis Pharmaceuticals (NASDAQ:IONS) won U.S. regulatory approval in December, . . .
Posted on 5/22/17
Why Berkshire Hathaway Shareholders Have Nothing to Worry About
Many investors bought shares of Berkshire Hathaway (NYSE:BRK-A) (NYSE:BRK-B) so they wouldn't have to worry too much about their investment. After all, who better to trust . . .
Posted on 5/22/17
Vertex Awards 40 Scholarships
BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the first recipients of the company’s All in for CF Scholarship program. Each of the 40 scholarship recipients . . .
Posted on 5/22/17
AVEO Oncology Announces Completion of a CHMP Oral Explanation for Tivozanib as a Treatment of First-Line Renal Cell Carcinoma
CAMBRIDGE, Mass.--(BUSINESS WIRE)--AVEO Oncology (NASDAQ:AVEO) today announced its European licensee for tivozanib, EUSA Pharma, has completed an oral explanation to the Committee for Medicinal Products for . . .
Posted on 5/18/17
Sage Therapeutics Receives Fast Track Designation for SAGE-217 for the Treatment of Major Depressive Disorder
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sage Therapeutics (NASDAQ: SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, today announced that the U.S. . . .
Posted on 5/17/17
Cogstate Selected as Preferred Provider to Lilly’s Alzheimer’s Disease Platform
NEW HAVEN, Conn.--(BUSINESS WIRE)--The cognitive science company, Cogstate Ltd (ASX:CGS) today announced it has been chosen as the preferred provider to the global healthcare leader, Eli . . .
Boston
